Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry.
about
Vaccination against respiratory Pseudomonas aeruginosa infectionPathophysiology of cystic fibrosis and drugs used in associated digestive tract diseasesCurrent and Emerging Therapies for the Treatment of Cystic Fibrosis or Mitigation of Its SymptomsGenotypic Diversity within a Single Pseudomonas aeruginosa Strain Commonly Shared by Australian Patients with Cystic FibrosisAn overview of international literature from cystic fibrosis registries. Part 5: Update 2012-2015 on lung disease.Changes in cystic fibrosis airway microbial community associated with a severe decline in lung function.Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis.The European Cystic Fibrosis Society Patient Registry: valuable lessons learned on how to sustain a disease registry.Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungiAssociation between spirometry controlled chest CT scores using computer-animated biofeedback and clinical markers of lung disease in children with cystic fibrosisSymptoms of depression impact the course of lung function in adolescents and adults with cystic fibrosisLung microbiota across age and disease stage in cystic fibrosis.Clinical outcomes associated with Staphylococcus aureus and Pseudomonas aeruginosa airway infections in adult cystic fibrosis patientsEvidence for a Cystic Fibrosis Enteropathy.Impact of Long-Term Tiotropium Bromide Therapy on Annual Lung Function Decline in Adult Patients with Cystic FibrosisLow forced expiratory volume is associated with earlier death in sickle cell anemiaFactors Associated with Worse Lung Function in Cystic Fibrosis Patients with Persistent Staphylococcus aureus.The Coupling of Peripheral Blood Pressure and Ventilatory Responses during Exercise in Young Adults with Cystic Fibrosis.The relationship between cardiac hemodynamics and exercise tolerance in cystic fibrosisAccurate reporting of adherence to inhaled therapies in adults with cystic fibrosis: methods to calculate "normative adherence".Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosisThe role for neutrophil extracellular traps in cystic fibrosis autoimmunity.Association of growth and nutritional parameters with pulmonary function in cystic fibrosis: a literature review.Innovative approach for self-management and social welfare of children with cystic fibrosis in Europe: development, validation and implementation of an mHealth tool (MyCyFAPP).Nutrition Management of Cystic Fibrosis in the 21st Century.2014 year in review: Cystic fibrosis.What can the CF registry tell us about rare CFTR-mutations? A Belgian study.Searching for a cure for cystic fibrosis. A 25-year quest in a nutshell.Body composition and lung function in children with cystic fibrosis and meconium ileus.Cystic Fibrosis and the Nervous System.Consequences of Expiratory Flow Limitation at Rest in Subjects with Cystic Fibrosis.Growth Deficiency in Cystic Fibrosis Is Observable at Birth and Predictive of Early Pulmonary Function.Pseudomonas aeruginosa antibiotic resistance in Australian cystic fibrosis centres.Association of chronic Candida albicans respiratory infection with a more severe lung disease in patients with cystic fibrosis.Clinical characteristics, functional respiratory decline and follow-up in adult patients with primary ciliary dyskinesia.IL-22 exacerbates weight loss in a murine model of chronic pulmonary Pseudomonas aeruginosa infectionStaphylococcus aureus and Pseudomonas aeruginosa co-infection is associated with cystic fibrosis-related diabetes and poor clinical outcomes.Consensus on the criteria needed for creating a rare-disease patient registry. A Delphi study.Population pharmacokinetics of inhaled tobramycin powder in cystic fibrosis patients.Coach to cope: feasibility of a life coaching program for young adults with cystic fibrosis.
P2860
Q26824014-ABEBB1AD-4286-48CB-BCDD-79657EDFC529Q26825799-2DD253DC-757F-40D3-BB6B-EF43B098D284Q28077411-F39D2827-4CBF-42DC-80BA-3251F67F2192Q28551306-E8EE21A1-6A56-4E74-910E-C10F030AC21FQ30244524-813A34E2-7EFF-4245-8FCD-6369F531C882Q30388877-94F5762D-C1B5-411B-9BEB-A943D60B1FD6Q33592546-FC29A81F-5A5C-4BAF-BDEB-201894A0BC11Q33789033-4C6133DC-6D59-47F2-89F6-B3C9C210F971Q33792765-B5417B84-1261-440B-99BD-DC50271D4B89Q33810871-F84052C0-EFB5-4CEE-BD37-7FB7B54C20A2Q34778559-D807CD67-089D-4D7B-9331-55CBEAEF87D7Q35605802-A2BEB408-5333-4C7C-A4C2-8E6C7934E874Q35669548-21EEFDEF-D163-448A-A5D2-F3337EDEF0FEQ35814231-74992EAE-7B75-44E8-9C33-CD29C712DACBQ36063173-79D2D2AF-F23B-482D-8C1D-F13E0DE3AA89Q36091274-97588B9F-C369-4CCC-A019-34680BC40003Q36197194-1A1748E9-7EE9-45E0-A2E9-616B6F0A255FQ36229674-082636A0-9750-4C28-AC95-4B30FF9965ABQ36880402-9791796F-9BEF-4FCD-8729-215499E23E83Q36944153-114A5834-17D0-4DEF-866B-46AE737F8F16Q36968540-79B13577-9059-4596-9B13-2FC90473626DQ37351609-59283945-2428-4BBA-852F-FD5C335DC292Q37524326-680D7FD7-A68B-4127-A50D-D9B7D8CECB8DQ37728233-C18B4362-8EA3-49F2-93A2-B65361521CA4Q38538310-303D6ADA-F121-4F95-9A90-CDCD33BECDA0Q38582563-17D371F5-AF3E-45C9-AE2C-CFA1446B25B5Q38613628-AAC882F6-7FE6-48E6-839B-9860F59D36ABQ38633196-034F094A-ECC7-4400-B06A-30B0FB3D1286Q38837301-DEB87340-F758-456C-A34E-EBCB8EC5548EQ39017146-0C9C5D14-D886-4CE7-BE54-996C873F4547Q39740014-4C0FCEBD-A03C-4810-98E4-196E07E2CA1BQ39849090-8BD42756-2190-4653-A972-E9ACC998013FQ40164055-38CB9FE4-6C3A-46A1-92CF-3A98577A64F8Q40525694-59F458F9-4021-4E5C-951B-FC7124847A0DQ40624144-9A41925A-C789-4F5E-BB96-9C8E21D836F2Q40626615-32EC4D22-4538-4FC7-84FA-DEB4C04C0874Q40749365-3BD1DEF0-40BB-4CCC-A572-0D3ACFE5B767Q41464582-D12C42D5-A837-40AA-90D8-6AAC317B86A2Q41907045-87C65F1E-29BD-4A84-851E-EF96342FBF00Q42364447-91E573FC-6613-4679-916B-3D6806576CD8
P2860
Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Factors associated with FEV1 d ...... of the ECFS patient registry.
@en
Factors associated with FEV1 d ...... of the ECFS patient registry.
@nl
type
label
Factors associated with FEV1 d ...... of the ECFS patient registry.
@en
Factors associated with FEV1 d ...... of the ECFS patient registry.
@nl
prefLabel
Factors associated with FEV1 d ...... of the ECFS patient registry.
@en
Factors associated with FEV1 d ...... of the ECFS patient registry.
@nl
P2093
P1476
Factors associated with FEV1 d ...... s of the ECFS patient registry
@en
P2093
Anna Zolin
ECFS Patient Registry Steering Group
Eitan Kerem
Hanne Olesen
Laura Viviani
Pavel Drevinek
Stephanie MacNeill
Uros Krivec
Vincent Gulmans
P304
P356
10.1183/09031936.00166412
P577
2013-04-18T00:00:00Z